BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30076415)

  • 21. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
    Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
    Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging role of nuclear factor kappa B in renal cell carcinoma.
    Morais C; Gobe G; Johnson DW; Healy H
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1537-49. PubMed ID: 21854869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
    Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
    PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
    Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth.
    Dormoy V; Danilin S; Lindner V; Thomas L; Rothhut S; Coquard C; Helwig JJ; Jacqmin D; Lang H; Massfelder T
    Mol Cancer; 2009 Dec; 8():123. PubMed ID: 20015350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma.
    Zhang J; Wu T; Simon J; Takada M; Saito R; Fan C; Liu XD; Jonasch E; Xie L; Chen X; Yao X; Teh BT; Tan P; Zheng X; Li M; Lawrence C; Fan J; Geng J; Liu X; Hu L; Wang J; Liao C; Hong K; Zurlo G; Parker JS; Auman JT; Perou CM; Rathmell WK; Kim WY; Kirschner MW; Kaelin WG; Baldwin AS; Zhang Q
    Science; 2018 Jul; 361(6399):290-295. PubMed ID: 30026228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
    He X; Wang J; Messing EM; Wu G
    Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective.
    Shenoy N; Pagliaro L
    Ann Oncol; 2016 Sep; 27(9):1685-95. PubMed ID: 27329246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
    Wang Y; Fu D; Chen Y; Su J; Wang Y; Li X; Zhai W; Niu Y; Yue D; Geng H
    Cell Death Dis; 2018 May; 9(5):501. PubMed ID: 29717134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma.
    Sampson VB; David JM; Puig I; Patil PU; de Herreros AG; Thomas GV; Rajasekaran AK
    PLoS One; 2014; 9(7):e102041. PubMed ID: 25025131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy.
    Sourbier C; Lindner V; Lang H; Agouni A; Schordan E; Danilin S; Rothhut S; Jacqmin D; Helwig JJ; Massfelder T
    Cancer Res; 2006 May; 66(10):5130-42. PubMed ID: 16707436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIM59 is a key regulator of growth and migration inrenal cell carcinoma.
    Hu SH; Zhao MJ; Wang WX; Xu CW; Wang GD
    Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):68-74. PubMed ID: 28719348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
    Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
    Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma.
    Dormoy V; Béraud C; Lindner V; Coquard C; Barthelmebs M; Brasse D; Jacqmin D; Lang H; Massfelder T
    Carcinogenesis; 2012 Nov; 33(11):2084-93. PubMed ID: 22843547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
    Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
    Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase.
    Petrella BL; Brinckerhoff CE
    Mol Cancer; 2006 Dec; 5():66. PubMed ID: 17140440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy.
    Sourbier C; Danilin S; Lindner V; Steger J; Rothhut S; Meyer N; Jacqmin D; Helwig JJ; Lang H; Massfelder T
    Cancer Res; 2007 Dec; 67(24):11668-76. PubMed ID: 18089796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
    Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
    Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.
    van der Horst G; Bos L; van der Mark M; Cheung H; Heckmann B; Clément-Lacroix P; Lorenzon G; Pelger RC; Bevers RF; van der Pluijm G
    PLoS One; 2014; 9(9):e108464. PubMed ID: 25247809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.